How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Close this folder2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contentsOrganization of the national formulary committee
View the documentAgreement on purpose, content, structure and format
View the documentFinancing
View the documentSelection of medicines to be included in the national formulary
View the documentDevelopment of the draft
View the documentReviewing and finalizing content
View the documentProduction, dissemination and implementation
View the documentEvaluation and review
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Evaluation and review

Evaluation of the availability, use and impact of the NF is best integrated with existing, regular monitoring and evaluation activities. In addition, specific surveys and/or interviews can also be conducted and the results of these, together with the written and verbal comments received from users, should be carefully considered in the review process.

The most recent edition of the WMF should be used in the scheduled revision of the NF and information from the updated WMF texts should be carefully transferred into subsequent editions of the NF.

During the review process, clear procedures will need to be established to cover deletion, addition and modification of entries in the revised NF as well as possible changes in scope and presentation.


Figure 2.1. Overview of the development and maintenance of a national formulary

WMF, WHO model formulary.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014